Since ATF5 has been shown to regulate asparagine synthetase expression, and asparaginase is a common treatment in childhood ALL, it is possible that interfering with ATF5 pathways in combination with asparaginase treatment could yield better patient outcomes. Here, ATF5 is linked to acute lymphoblastic leukemia.